In nonfunctioning pituitary adenomas, cabergoline (NCT02288962, Phase III, active) activates D2R to inhibit proliferation, whereas in recurrent diffuse midline gliomas, ONC206 (NCT04732065, Phase I, recruiting) inhibits D2R to induce apoptosis. This evidence concerns the gene DRD2 and pituitary gland adenoma.